Literature DB >> 7741893

Constitutive muscular abnormalities in culture in spinal muscular atrophy.

S Braun1, B Croizat, M C Lagrange, J M Warter, P Poindron.   

Abstract

To explore the cause of spinal muscular atrophy (SMA), we used an in-vitro model of nerve-muscle co-cultures in which motoneurons were normal and satellite cells were obtained from SMA patients. In co-cultures initiated with satellite cells from type I and type II SMA patients only, we observed degeneration of the innervated fibres after 1-3 weeks of nerve-muscle co-culture. This process involved vacuolisation, disorganisation, and death of the innervated muscle fibres. This observation points to a muscular implication in the severe forms of SMAs.

Entities:  

Mesh:

Year:  1995        PMID: 7741893     DOI: 10.1016/s0140-6736(95)90869-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

1.  Genetic adaptation controlled by methylations and acetylations at the nuclear and cytosolic levels: a hypothetical model.

Authors:  Maurice Israël
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.

Authors:  Tara L Martinez; Lingling Kong; Xueyong Wang; Melissa A Osborne; Melissa E Crowder; James P Van Meerbeke; Xixi Xu; Crystal Davis; Joe Wooley; David J Goldhamer; Cathleen M Lutz; Mark M Rich; Charlotte J Sumner
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

3.  Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.

Authors:  Chitra C Iyer; Vicki L McGovern; Jason D Murray; Sara E Gombash; Phillip G Zaworski; Kevin D Foust; Paul M L Janssen; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

Review 4.  Molecular genetics of autosomal recessive spinal muscular atrophy.

Authors:  N R Rodrigues; K Talbot; K E Davies
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

5.  Gene deletions in spinal muscular atrophy.

Authors:  N R Rodrigues; N Owen; K Talbot; S Patel; F Muntoni; J Ignatius; V Dubowitz; K E Davies
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

6.  Androgen receptors in muscle fibers induce rapid loss of force but not mass: implications for spinal bulbar muscular atrophy.

Authors:  Kentaro Oki; Robert W Wiseman; S Marc Breedlove; Cynthia L Jordan
Journal:  Muscle Nerve       Date:  2013-04-30       Impact factor: 3.217

7.  Drug treatment for spinal muscular atrophy types II and III.

Authors:  Renske I Wadman; W Ludo van der Pol; Wendy Mj Bosboom; Fay-Lynn Asselman; Leonard H van den Berg; Susan T Iannaccone; Alexander Fje Vrancken
Journal:  Cochrane Database Syst Rev       Date:  2020-01-06

8.  Reorganization of the nuclear compartments involved in transcription and RNA processing in myonuclei of type I spinal muscular atrophy.

Authors:  María S Castillo-Iglesias; María T Berciano; J Oriol Narcis; J Fernando Val-Bernal; José C Rodriguez-Rey; Olga Tapia; Miguel Lafarga
Journal:  Histochem Cell Biol       Date:  2019-06-11       Impact factor: 4.304

9.  A cell-autonomous defect in skeletal muscle satellite cells expressing low levels of survival of motor neuron protein.

Authors:  Monica Hayhurst; Amanda K Wagner; Massimiliano Cerletti; Amy J Wagers; Lee L Rubin
Journal:  Dev Biol       Date:  2012-06-15       Impact factor: 3.582

10.  Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.

Authors:  Suzan M Hammond; Gareth Hazell; Fazel Shabanpoor; Amer F Saleh; Melissa Bowerman; James N Sleigh; Katharina E Meijboom; Haiyan Zhou; Francesco Muntoni; Kevin Talbot; Michael J Gait; Matthew J A Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.